User: Guest

FLOW CYTOMETRY PRODUCTS AND SERVICES

Global Market Trajectory & Analytics

MCP-3511

VALIDATED EXECUTIVE ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

4074

Interactions with Platform & by Email *

INTERACTIONS

733

Unique # Participated *

PARTICIPANTS

122

Responses Validated *

VALIDATIONS

56

* Login to view program details and full enterprise executive list.


  •  DATE

    SEPTEMBER 2020

  •  TABLES

    303

  •  PAGES

    386

  •  EDITION

    18

  •  PRICE

    USD $5450


COVID-19 IMPACT SURVEY
Amid the COVID-19 crisis, the global market for Flow Cytometry Products and Services estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at aCAGR of 6.9% over the period 2020-2027. Cell-Based Flow Cytometry, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bead-Based Flow Cytometry segment is readjusted to a revised 7% CAGR for the next 7-year period.
The Flow Cytometry Products and Services market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.We bring years of research experience to this 18th edition of our report. The 386-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others, Agilent Technologies, Inc.; Apogee Flow Systems Ltd.; Beckman Coulter, Inc.; Becton, Dickinson and Company; bioMerieux SA; Bio-Rad Laboratories, Inc.; Cytonome/ST, LLC; Enzo Life Sciences, Inc.; Luminex Corporation; Merck KGaA; Miltenyi Biotec GmbH; Sony Biotechnology, Inc.; Stratedigm, Inc.; Sysmex Partec GmbH; Thermo Fisher Scientific, Inc.
» Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry) » Product & Service (Reagents & Consumables, Flow Cytometry Instruments, Services, and Software) » Application (Research Application, Clinical Application, and Industrial Application)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

  • A: 
    ACTIVE CLIENT
  • B: 
    INACTIVE CLIENT
  • C: 
    ACTIVE PANELIST
  • D: 
    INACTIVE PANELIST
  • E: 
    OPT-INS
  
REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL